ANS drugs Flashcards
systemic effects of cholinomimetic drugs
Increase ACh activity:
- miosis, accommodation
- decrease heart rate by decreasing conduction velocity
- Increase secretions (glands, sweating, lacrimation, salivation)
- Increase GI/GU motility by relaxing external sphincters and increasing secretion
- bronchoconstriction and increased secretion in lung
Contraindications for cholinomimetics
COPD, asthma, peptic ulcers
examples of direct acting cholinomimetics (4)
Bethanechol, carbachol, methacholine, pilocarpine
Bethanechol: class and clinical use
direct acting muscarinic agonist: post op ileus, neurogenic ileus, urinary retention
Carbachol: class and clinical use
direct acting muscarinic agonist: constrict pupil for glaucoma patients
Methacholine: class and clinical use
direct acting muscarinic agonist: challenge test to Dx asthma
Pilocarpine: class and clinical use
direct acting muscarinic agonist: stimulate sweating (CF sweat test), tears, salivation (dry mouth in Sjogrens), constrict pupil for glaucoma
Mechanism of indirect acting cholinomimetics
Anticholinesterases
-stigmines: class
AChE inhibitors
Donepezil: class and clinical use
AChE inhibitor: Alzheimer disease
Galantamine: class and clinical use
AChE inhibitor: Alzheimer
Rivastigmine: class and clinical use
AChE inhibitor: Alzheimer
Edrophonium: class and clinical use
AChE inhibitor: Dx myasthenia gravis
Which anticholinesterase is used to Dx myesthenia gravis? Which is used to treat it? What is the difference between the two
Edrophonium: Pyridostigmine (and neostigmine): the length of time that they remain active
Which AChE inhibitor crosses the BBB? When is it used?
physostigmine: atropine (muscarinic antagonist) overdose